Search results
From Self-sufficiency
- ...t al.'' |title=Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans |journal=Ann. Intern. Med. |volume=78 |issue=4 ...siness, loss of consciousness, [[respiratory depression]] and [[apnoea]]). Cardiovascular effects include [[hypotension]], [[bradycardia]], [[arrhythmia]]s, and/or [15 KB (2,006 words) - 16:41, 27 September 2010
- * Asthmatics or patients with chronic obstructive airway disease '''''[[Cardiovascular]]:'''''69 KB (9,697 words) - 21:01, 24 September 2010
- ...ent factors. Among patient factors are: age, sex, lean body mass. Specific disease conditions that can alter the dose requirements of thiopentone and for that ...arly all [[anesthesia|anesthetic]] [[Medication|drug]]s, thiopental causes cardiovascular and respiratory depression resulting in [[hypotension]], [[apnea]] and [[ai24 KB (3,339 words) - 16:46, 27 September 2010
- | title=Slowing disease's mental ravages ...and increase [[complex IV]], whose inhibition correlates with Alzheimer's disease.27 KB (3,650 words) - 16:46, 27 September 2010
- ...he only anti-diabetic drug that has been conclusively shown to prevent the cardiovascular complications of diabetes. {{As of|2009}}, metformin is one of only two ora ...erlands, September 2007|journal=The British Journal of Diabetes & Vascular Disease|volume=7|pages=247–252 |year=2007|doi=10.1177/14746514070070051001}}</ref66 KB (8,976 words) - 16:47, 27 September 2010
- ...t al.'' |title=Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised ....2% to 6.7% of such events per year for people already with cardiovascular disease. Although aspirin also raises the risk of [[Stroke#Hemorrhagic_stroke|hemor78 KB (10,918 words) - 16:52, 27 September 2010
- ...on-steroidal anti-inflammatory medicines, medicines used to treat gout and disease modifying agents in rheumatoid disorders== ===Disease modifying agents used in rheumatoid disorders (DMARDs)===16 KB (1,353 words) - 21:21, 3 October 2011
- ...locker|β-blockers]]), a class of drugs used primarily in [[cardiovascular disease]]s. Introduced in 1976, atenolol was developed as a replacement for [[propr ...rction]] (heart attack). It is also used to treat the symptoms of [[Graves Disease]], until [[antithyroid]] medication can take effect.12 KB (1,720 words) - 16:48, 27 September 2010
- ...olemia]] (elevated [[cholesterol]] levels) and to prevent [[cardiovascular disease]]. Simvastatin is a synthetic derivate of a fermentation product of ''[[As ...astatin is associated with a reduced incidence of dementia and Parkinson's disease | journal =BMC Medicine | volume =5 | pages =20 | date =July 19, 2007 | doi14 KB (1,967 words) - 16:48, 27 September 2010
- ...he jejunum. Perfusion studies in normal subjects and patients with coeliac disease |journal=Scand. J. Gastroenterol. |volume=16 |issue=5 |pages=667–71 |year ...he pain in rheumatoid arthritis since cell potassium is always low in that disease <ref>LaCelle PL et al. (1964) “An investigation of total body potassium i41 KB (5,644 words) - 16:50, 27 September 2010
- ...send KP, Praticò D |title=Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs |journal=FASEB J. |volume=19 ...|title=Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease |journal=Ann Neurol |volume=58 |issue=6 |pages=963–7 |year=2005 |pmid=16229 KB (3,955 words) - 22:17, 21 September 2010
- '''''[[Cardiovascular]]:''''' .../www.amusingfacts.com/facts/Detail/soldiers-disease-morphine.html Soldiers Disease A Historical Hoax?]</ref>87 KB (12,376 words) - 16:51, 27 September 2010
- ...parison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man.''] Br J Clin Pharmacol. '''1978'''; 6, pp 2 *Cardiovascular: [[tachycardia]], cardiac [[arrhythmia]]s, [[angina pectoris]], [[vasoconst21 KB (2,906 words) - 16:51, 27 September 2010
- ...], [[alcohol withdrawal]], [[benzodiazepine withdrawal]] and [[Ménière's disease]]. It may also be used before certain medical procedures (such as [[endosco ...umazenil may be necessary. [[Artificial respiration]] and stabilization of cardiovascular functions may also be necessary. Although not routinely indicated, [[activa78 KB (10,295 words) - 16:51, 27 September 2010
- ...David A. |last=McCarron |title=Dietary sodium and cardiovascular and renal disease risk factors: dark horse or phantom entry? |journal=Nephrol Dial Transplant19 KB (2,579 words) - 16:51, 27 September 2010
- ...t=Free full text}}</ref><ref name="CDC">{{cite journal |author=Centers for Disease Control and Prevention (CDC) |title=Water hemlock poisoning--Maine, 1992 |j ...|dilated pupils]], and [[coma]].<ref name="Schep"/><ref name="Mutter"/> [[Cardiovascular]] symptoms include alternating [[bradycardia|slow]] or [[tachycardia|fast h29 KB (4,114 words) - 12:26, 7 July 2010
- ...with an [[antacid]]) for the relief of pain associated with [[peptic ulcer disease]] or [[esophagitis]]. It is also used topically in the management of [[hemo {{cardiovascular-drug-stub}}2 KB (286 words) - 09:43, 20 September 2010
- The drug is gaining acceptance for conservative treatment of [[Peyronie's disease]] and [[Neuropathy|neuropathic]] injuries. It also helps prevent strokes and can be used in managing [[sickle cell disease]].7 KB (885 words) - 09:43, 20 September 2010
- ...y 2010}}}}</ref> initially developed in the treatment of [[coronary artery disease]]. ...was found that may lower HDL in patients with a previous history of heart disease.3 KB (379 words) - 09:43, 20 September 2010
- ...the ductus arteriosus in an infant with ductal-dependent congenital heart disease, including cyanotic lesions (e.g., pulmonary atresia/stenosis, tricuspid at {{cardiovascular-drug-stub}}4 KB (610 words) - 09:43, 20 September 2010
